Can personalized insulin plans help kids with a rare, stubborn form of diabetes?

Imagine your child has type 1 diabetes, but on top of that, their immune system starts attacking the very insulin they need to survive. This rare and frustrating condition, called exogenous insulin antibody syndrome (EIAS), makes blood sugar wildly unpredictable. Doctors at one center looked back at how they managed five children facing this double challenge. They tried different, highly personalized strategies for each child, like switching insulin types, changing how it was delivered, or adding a medication that calms the immune system. For four of the five kids, these tailored approaches helped them spend more than 70% of their time in a healthy blood sugar range. The fifth child, whose case was more stubborn, saw improvement with the immune-calming drug, but their blood sugar became unstable again within a month of stopping it. It’s crucial to remember this is a report on just five children from one hospital, with no comparison group. The findings don’t prove what caused the improvements, but they offer a detailed, real-world look at what doctors tried when standard care wasn't enough. They highlight that for these rare cases, continuous glucose monitors are essential tools, as the usual A1c test can miss dangerous swings. This work points to questions for future, more rigorous studies to answer.